Podcasts

May 19, 2022

Benjamin Nowell, PhD, and Stuart Silverman, MD, FACP, FACR, discuss the recently published review of current literature regarding cannabis for rheumatic disease pain.

April 11, 2022

W Benjamin Nowell, PhD, and David Curtis discuss the recent press release announcing updates to the ArthritisPower interface.

March 14, 2022

Soumya D. Chakravarty, MD, PhD, discusses the growing body of clinical evidence evaluating joint efficacy, safety, and patient-reported outcomes in patients with psoriatic arthritis receiving guselkumab.

February 23, 2022

On this month's episode of Overdrive, Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a network meta-analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.

December 22, 2021

Louis Bessette, MD, MSc, explains the impact of early pain improvement on patient-reported outcomes in patients with psoriatic arthritis.

December 06, 2021

On this month's episode of Overdrive, Rheumatology Network interviewed Courtney Wells, PhD, MPH, MSW, to discuss the impact of COVID-19 on the quality of life of patients with rheumatic conditions, focusing on perceived risk and decision making.

November 24, 2021

Soumya Chakravarty, MD, PhD, discusses the unmet patient needs in immune-mediated diseases and Janssen’s role in scientific innovation that allows patients to live their lives unburdened by disease.

October 25, 2021

On this month's episode of Overdrive, E Michael Lewiecki, MD, discusses recent controversies and trends in osteoporosis management, predictions for 2022, and how COVID-19 impacted the treatment landscape for rheumatologists.

August 03, 2021

On this month's episode of Overdrive, Roy Fleischmann, MD, discusses the recent Pfizer press release regarding the safety of JAK inhibitors and his personal opinions on prescribing JAK inhibiting drugs to his patients.

July 13, 2021

On the latest episode of Overdrive, we sat down with Andrew L Concoff MD, FACR, CAQSM, to discuss value-based care, including the benefits, collaborate approach to working with payers, the revenue and cost savings, and how value-based care can support routine and consistent health visits.